Sino Biopharmaceutical (HK:1177) has released an update.
Sino Biopharmaceutical’s subsidiary, Chia Tai Tianqing, has purchased 16.8 million shares as part of its Share Incentive Scheme, representing 0.09% of the company’s total shares. This initiative is aimed at implementing share-based incentives for selected participants, with shares valued at approximately HKD3.65 each, totaling around HKD61.26 million. The board continues to review and determine future share distributions under this scheme.
For further insights into HK:1177 stock, check out TipRanks’ Stock Analysis page.
